Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

DHT affects testicular development and regulates spermatogenesis in some fish.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

Caucasian men have more chest hair and higher levels of certain androgen products than Chinese men.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

Morphine increases testosterone breakdown in the rat brain and spinal cord.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Ovarian volume is significantly related to higher levels of certain hormones in Korean women with PCOS.

Higher levels of certain hormones and lower levels of minerals may contribute to hair loss.

A woman's excess male hormone symptoms were caused by a rare benign tumor in her ovary.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Finasteride reduces certain hormone levels to treat prostate issues.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Hyperbaric oxygen therapy improves hair growth and quality of life in androgenic alopecia patients.

Finasteride effectively treats male pattern baldness.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

New treatments for male hypogonadism are effective and should be personalized.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.